27 September 2020
1300 794 893
Subscribe

Small & Micro Caps

Could Enviro Friendly EuroManganese Ltd have strategic advantage in Europe’s EV Hub?

EuroManganese Ltd. (ASX:EMN) is capturing investor attention by developing a waste recycling operation to extract high purity manganese products for the manufacture of lithium ion batteries.

Melbourne-based biotech submits Duchenne Muscular Dystrophy drug for US and EU Orphan Drug designation

Antisense Therapeutics (ANP) has submitted its antisense drug for Orphan Drug Designation with the US Food and Drug Administration (FDA), and is seeking similar designation in the European market with its application to the European Medicines Agency (EMA) Committee for Orphan Medicinal Products.

Scoping Study puts Minbos one step closer to creating food security in sub-Saharan Africa

More fertiliser, cheaply available, would see sub-Saharan Africa catch up to more developed countries’ food production, and remove their reliance on food imports.

MyFiziq body measurement technology heads to the Apple and Google app stores

In a collaboration with multi-sided health platform Bearn, MyFiziq (ASX: MYQ) technology will be accessible to Bearn's 25 million pre-registered users.

Meet the ASX-listed biotech tapping into unclaimed medical territory

Melbourne-based small cap Antisense Therapeutics (ANP) aims to develop antisense drugs for under-researched diseases where there is a clear need for better treatments.

Alexium creates breakthrough technology for thermal management

Alexium International Group Limited (ASX: AJX) has announced a breakthrough technology for thermal management in textile and foam-based consumer products.

A win for cyber security exchange WhiteHawk

WhiteHawk secures milestone $5.9 million cybersecurity contract with the US Federal Government!

Gold production in sight at Classic Minerals’ Kat Gap WA project

Western Australian gold exploration and development company Classic Minerals Limited has shifted its focus to preparing its Kat Gap Project for production.

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
1300 794 893
© 2006-2020 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
homephoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram